Skip to content

May 7, 2026

Home
Signal News
Biopharma Brief
Week in Review
Contact

Light/Dark Button

Search for:

Home
M&A / Deals
Roche buys AI-powered diagnostics player PathAI

M&A / Deals

Roche buys AI-powered diagnostics player PathAI

Pharmaphorum

Roche has been working with US AI specialist PathAI for around five years, and has now upgraded that partnership with an offer to buy it for $1.05bn.

Read full story

pharminent May 7, 2026 (Last updated: May 7, 2026)

Pharmaphorum

Roche has been working with US AI specialist PathAI for around five years, and has now upgraded that partnership with an offer to buy it for $1.05bn.

Read full story

Post navigation

Previous: Daiichi Sankyo and Waiv partner for ADC biomarkers

Next: Bayer plans filings for cardiac amyloidosis imaging agent

Related Stories

M&A / Deals

Angelini inks $4.1B Catalyst buy to enter US rare disease market

pharminent May 7, 2026

M&A / Deals

Daiichi Sankyo and Waiv partner for ADC biomarkers

pharminent May 7, 2026

M&A / Deals

Bayer to buy Perfuse for up to $2.45B, bolstering eye drug pipeline

pharminent May 6, 2026

You May Have Missed

Regulatory

FDA reverses course on Atara, Pierre Fabre’s twice-rejected cell therapy after Prasad’s exit

pharminent May 7, 2026

M&A / Deals

Angelini inks $4.1B Catalyst buy to enter US rare disease market

pharminent May 7, 2026

Regulatory

Bayer plans filings for cardiac amyloidosis imaging agent

pharminent May 7, 2026

M&A / Deals

Roche buys AI-powered diagnostics player PathAI

pharminent May 7, 2026

Copyright © 2026 All rights reserved. | ReviewNews by AF themes.